Haleon saw the highest growth of 139% in patent filings in February and 299% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 70% and grants by 79%. GlobalData’s DataBook provides a comprehensive analysis of Haleon‘s patent filings and grants. Buy the databook here.
Haleon has been focused on protecting inventions in United States(US) with seven publications in Q1 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 38% grants. The United States(US), Japan(JP), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Haleon is filings its patents. Among the top granted patent authorities, Haleon has 38% of its grants in United States(US), 25% in Australia(AU) and 25% in Canada(CA).
Procter & Gamble could be the strongest competitor for Haleon
Patents related to rare diseases and health & wellness lead Haleon's portfolio
Haleon has the highest number of patents in rare diseases followed by, health & wellness and microbiome. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q1 2024.
Mobiles, hand-helds, pdas, smartphones related patents lead Haleon portfolio followed by cosmetics & toiletries, and inflammation
Haleon has highest number of patents in mobiles, hand-helds, pdas, smartphones followed by cosmetics & toiletries, inflammation, denture fixatives, and packaging. For mobiles, hand-helds, pdas, smartphones, nearly 7% of patents were filed and 12% of patents were granted in Q1 2024.
For comprehensive analysis of Haleon's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.